Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Farb

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 1, 2023
The medical device development ecosystem: Current regulatory state and challenges for future development: A reviewDavid R Holmes, Andrew Farb, Nabil Dib, et al.
Journal of the American College of Cardiology|November 28, 2009
Microemboli and microvascular obstruction in acute coronary thrombosis and sudden coronary death: relation to epicardial plaque histopathologyRobert S Schwartz, Allen Burke, Andrew Farb, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2002
Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosionFrank D Kolodgie, Allen P Burke, Andrew Farb, et al.
Hawaii Medical Journal|January 2, 2004
Spontaneous coronary artery dissection in a patient with systemic lupus erythematosisArvind K Sharma, Andrew Farb, Parimal Maniar, et al.
Circulation|January 30, 2002
Traditional risk factors and the incidence of sudden coronary death with and without coronary thrombosis in blacksAllen P Burke, Andrew Farb, Joseph Pestaner, et al.
Circulation|November 20, 2002
Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humansRenu Virmani, Francesco Liistro, Goran Stankovic, et al.
JACC. Cardiovascular Interventions|June 23, 2012
Pathology of drug-eluting versus bare-metal stents in saphenous vein bypass graft lesionsSaami K Yazdani, Andrew Farb, Masataka Nakano, et al.
Journal of the American College of Cardiology|October 22, 2016
Overcoming the Challenges of Conducting Early Feasibility Studies of Medical Devices in the United StatesDavid R Holmes, Robert Califf, Andrew Farb, et al.
Circulation|April 14, 2025
Patient-Reported Outcomes as End Points in Heart Failure TrialsJaved Butler, Muhammad Shariq Usman, Charu Gandotra, et al.
Journal of Neurosurgery|June 4, 2021
US FDA best practices for initiating early feasibility studies for neurological devices in the United StatesRobert Herrmann, Maureen Dreher, Andrew Farb, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 1, 2023
The medical device development ecosystem: Current regulatory state and challenges for future development: A reviewDavid R Holmes, Andrew Farb, Nabil Dib, et al.
Journal of the American College of Cardiology|November 28, 2009
Microemboli and microvascular obstruction in acute coronary thrombosis and sudden coronary death: relation to epicardial plaque histopathologyRobert S Schwartz, Allen Burke, Andrew Farb, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2002
Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosionFrank D Kolodgie, Allen P Burke, Andrew Farb, et al.
Hawaii Medical Journal|January 2, 2004
Spontaneous coronary artery dissection in a patient with systemic lupus erythematosisArvind K Sharma, Andrew Farb, Parimal Maniar, et al.
Circulation|January 30, 2002
Traditional risk factors and the incidence of sudden coronary death with and without coronary thrombosis in blacksAllen P Burke, Andrew Farb, Joseph Pestaner, et al.
Circulation|November 20, 2002
Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humansRenu Virmani, Francesco Liistro, Goran Stankovic, et al.
JACC. Cardiovascular Interventions|June 23, 2012
Pathology of drug-eluting versus bare-metal stents in saphenous vein bypass graft lesionsSaami K Yazdani, Andrew Farb, Masataka Nakano, et al.
Journal of the American College of Cardiology|October 22, 2016
Overcoming the Challenges of Conducting Early Feasibility Studies of Medical Devices in the United StatesDavid R Holmes, Robert Califf, Andrew Farb, et al.
Circulation|April 14, 2025
Patient-Reported Outcomes as End Points in Heart Failure TrialsJaved Butler, Muhammad Shariq Usman, Charu Gandotra, et al.
Journal of Neurosurgery|June 4, 2021
US FDA best practices for initiating early feasibility studies for neurological devices in the United StatesRobert Herrmann, Maureen Dreher, Andrew Farb, et al.
Pageof 10